Epithelioid granulomatous lesions express abundant programmed death ligand-1 (PD-L1): a discussion of adverse events in anti-PD-1 antibody-based cancer immunotherapy

Terufumi Kuboa Department of Pathology, Sapporo Medical University, School of Medicine, Sapporo, JapanCorrespondence[email protected]

Yoshihiko Hirohashia Department of Pathology, Sapporo Medical University, School of Medicine, Sapporo, JapanCorrespondence[email protected]

Tomohide Tsukaharaa Department of Pathology, Sapporo Medical University, School of Medicine, Sapporo, Japan

Takayuki Kanasekia Department of Pathology, Sapporo Medical University, School of Medicine, Sapporo, Japan

Kenji Murataa Department of Pathology, Sapporo Medical University, School of Medicine, Sapporo, Japan

Tadashi Hasegawab Department of Surgical Pathology, Sapporo Medical University Hospital, Sapporo, Japan

Toshihiko Torigoea Department of Pathology, Sapporo Medical University, School of Medicine, Sapporo, Japan

Your download is now in progress and you may close this window